J. B. Chemicals & Pharmaceuticals Limited J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

JBCHEPHARM

Peringkat dalam Saham #3892
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Harga Saham
$26.58
Terakhir disinkronkan: 2026-07-23
Kapitalisasi Pasar
$4.24B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
38.14%
Negara
IN
Perdagangan J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

Kategori

Healthcare
Rasio P/S untuk J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Rasio P/S per October 2026 TTM: 9.35
Menurut laporan keuangan dan harga saham terbaru dari J. B. Chemicals & Pharmaceuticals Limited, rasio P/S saat ini (TTM) adalah 9.35. Pada akhir 2024, rasio P/S perusahaan adalah 7.54.
Riwayat rasio P/S untuk J. B. Chemicals & Pharmaceuticals Limited dari 2005 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 9.35 48.93%
2025 6.28 -16.71%
2024 7.54 53.78%
2023 4.90 -2.38%
2022 5.02 3.84%
2021 4.84 110.26%
2020 2.30 21.87%
2019 1.89 -0.31%
2018 1.89 -15.47%
2017 2.24 23.70%
2016 1.81 12.32%
2015 1.61 39.47%
2014 1.16 40.76%
2013 0.82 27.61%
2012 0.64 -51.50%
2011 1.33 64.39%
2010 0.81 88.62%
2009 0.43 -42.68%
2008 0.75 -40.69%
2007 1.26 -36.45%
2006 1.98 7.09%
2005 1.85 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing